Concepedia

E. Ann Hallinan

EA

Statistics

Publications

15

Citations

840

H-Index

15

Active since

1971

Affiliations

Monsanto (United States)(Current)

University of Chicago

Sears Holdings (United States)

E. Ann Hallinan is an author at Monsanto (United States) specializing in pharmacology, medicinal chemistry, and molecular pharmacology.

Publications per year

1971–2004

15

Publications

15

2,2-Difluoro-3-hydroxyesters by reformatskii reaction

E. Ann Hallinan, Josef Fried · Tetrahedron Letters · 1984 · 146 citations

, , +1

Synthesis and Biological Characterization of L-N<sup>6</sup>-(1-Iminoethyl)lysine 5-Tetrazole-amide, a Prodrug of a Selective iNOS Inhibitor

E. Ann Hallinan, Sofya Tsymbalov, Clifford R. Dorn et al. · Journal of Medicinal Chemistry · 2002 · 77 citations · Full text

, , +10

Seeds as sources of L-Dopa

M. E. Daxenbichler, C. H. VanEtten, E. Ann Hallinan et al. · Journal of Medicinal Chemistry · 1971 · 75 citations

, , +6

N-Substituted dibenzoxazepines as analgesic PGE2 antagonists

E. Ann Hallinan, Timothy J. Hagen, Robert K. Husa et al. · Journal of Medicinal Chemistry · 1993 · 72 citations

, , +12

8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid,2-[3-[2-(furanylmethyl)thio]-1-oxopropyl]hydrazide (SC-51322): A potent PGE2 antagonist and analgesic

E. Ann Hallinan, Awilda Stapelfeld, Michael A. Savage et al. · Bioorganic & Medicinal Chemistry Letters · 1994 · 68 citations

, , +7

1–5 of 15